Acadia

Acadia has committed $125 million (23%) of Fund IV's total capital commitments.

Acadia is a vertically-integrated organization whose investment experience includes debt restructuring, recapitalization, value-add re-leasing, and asset repositioning and redevelopment.

Global Market Direct's pharmaceuticals report, ACADIA Pharmaceuticals Inc.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, ACADIA Pharmaceuticals Inc.

Commenting on the announcement, Joey Jacobs, Chairman and Chief Executive Officer of Acadia, said, "The completion of this merger brings a great team of dedicated and skilled professionals to Acadia and an outstanding portfolio of facilities and services.

Factors that may cause actual results to differ materially include the risk that (i) payments received from the government and third-party payors may be reduced; (ii) Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; (iii) the businesses of Acadia and Pioneer Behavioral Health may not be integrated successfully; and (iv) Acadia may not be able to identify, finance and integrate future acquisitions.